Diversion of HIV-1 vaccine–induced immunity by gp41-microbiota cross-reactive antibodiesWilton B. Williams, Barton F. Haynes, Hua-Xin Liao et al.|Science|2015Cited by 202
FCGR2C polymorphisms associate with HIV-1 vaccine protection in RV144 trialShuying S. Li, Daniel E. Geraghty, Chul-Woo Pyo et al.|Journal of Clinical Investigation|2014Cited by 109
Vaccination With Heterologous HIV-1 Envelope Sequences and Heterologous Adenovirus Vectors Increases T-Cell Responses to Conserved Regions: HVTN 083Stephen R. Walsh, Xia Jin, Zoe Moodie et al.|The Journal of Infectious Diseases|2015Cited by 25